Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age

This randomized trial conducted in France compared intramuscular (IM) and subcutaneous (SC) administration of two doses of a measles, mumps, rubella, and varicella (MMRV) combination vaccine (ProQuad®) administered one month apart to 405 children 12–18 months of age (NCT00402831). The 2-dose regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Hervé, Richard, Patrick, Eymin, Cécile, Fiquet, Anne, Kuter, Barbara, Soubeyrand, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605874/
https://www.ncbi.nlm.nih.gov/pubmed/30481110
http://dx.doi.org/10.1080/21645515.2018.1549452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605874/
https://www.ncbi.nlm.nih.gov/pubmed/30481110
http://dx.doi.org/10.1080/21645515.2018.1549452

Ejemplares similares